ArticleSouthern African journal of infectious diseases2022

Best practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa.

Adrian J Brink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.